The GLP-1 Club
Intelligence Report
Every health club chain partnering, prescribing, or programming around GLP-1 weight loss medications — mapped and analyzed as of March 2026.
taken a GLP-1 (Gallup)
by 2030 (JPMorgan)
a gym membership
(Planet Fitness, Q4 2025)
with active GLP-1 programs
Executive Summary
The convergence of GLP-1 weight loss medications and the fitness industry has accelerated dramatically. What started as luxury gym experiments in 2023 has expanded across every market segment — from premium clubs prescribing directly, to budget chains partnering with telehealth platforms, to boutique franchises launching bundled medication-and-fitness programs.
This report tracks 17 fitness clubs and 10 solution providers that have taken concrete action in the GLP-1 space as of March 2026.
Key Findings
The fitness-as-medicine model is going mainstream. Life Time, UFC GYM, Monarch, and Love.Life have moved into direct clinical integration — offering physician-supervised GLP-1 programs directly at club locations.
Budget gyms are firmly in the referral lane. Planet Fitness's Ro partnership is the first major High-Value, Low-Price (HVLP) play and operates as a referral-only model. Crunch Fitness has deepened member engagement through a new Thrive partnership. Anytime Fitness franchisees are forming local clinic partnerships.
Telehealth platforms are the connective tissue. Dr. B alone has partnered with F45, Anytime Fitness, and others. NexGen MD powers UFC GYM's in-club longevity clinics. Ro powers Planet Fitness. Idexa360 supports Gold's Gym.
Trainers are the missing piece. Nearly every program emphasizes resistance training and nutrition guidance to prevent muscle loss. The industry needs trainers who understand GLP-1 pharmacology effects and can deliver safe, effective programming for this growing member segment.
The BALANCE Model creates a new revenue category. The Centers for Medicare & Medicaid Services (CMS) requires GLP-1 Medicare/Medicaid patients to enroll in a lifestyle support program — opening the door for brands to become certified government-authorized lifestyle providers starting May 2026.
Executive Summary
Health clubs approach GLP-1 integration along a spectrum. Understanding where each model sits helps operators evaluate which approach fits their brand, resources, and risk tolerance.
Key Solution Providers
B2B platforms providing clinical, regulatory, and technology infrastructure for fitness clubs entering the GLP-1 space.
The GLP-1 Club Tracker
Selected health club and boutique fitness brands with concrete GLP-1 action as of March 2026.
Note: Location counts are approximate.
New This Quarter
Feb 25, 2026
UFC GYM + NexGen MD Scientific JV
In-club longevity clinics offering brand-name FDA-approved GLP-1s, peptides, and Hormone Replacement Therapy (HRT). Torrance and Corona CA, May 2026. Full rollout over 24 months.
Feb 24, 2026
Planet Fitness Q4 Earnings
CEO: Ro partnership is "most successful Perks program in history." 20.8M members. Ro referral model only — brand-name Wegovy prescriptions.
Q1 2026
Crunch Fitness + Thrive Partnership
Crunch Fitness (550+ locations) partnered with Thrive to bring GLP-1 medication access and programming support to members across its network. Expands telehealth-fitness integration into the HVLP segment.
August 2025
In-Shape Family Fitness + KORB Health Partnership
In-Shape Family Fitness (63 CA locations) partnered with KORB Health to offer white-label clinical integration with GLP-1s. Marks one of the first regional chain GLP-1 integrations via white-label pharmaceutical supply.
Q1 2026
YMCA GLP-1 Programming — Grassroots Movement
Select YMCA locations have launched dedicated Ozempic/Wegovy programming classes alongside body composition scanning — a community-health-driven approach to GLP-1 fitness integration.
Sept 2025
Xponential Divests Lindora to Next Health
Xponential sold Lindora metabolic clinics and refocused on its studio portfolio (Club Pilates, Pure Barre, Rumble, YogaSix). Next Health now operates Lindora's 30+ clinic network.
Q1 2026
Arena Club Launches GLP-1 Program
Partnered with Prime Meridian Health (Utah) to offer 12-month semaglutide + coaching program. Physician-supervised GLP-1 programs with integrated fitness support.
Dec 22, 2025 / Jan 2026
Wegovy 25mg Oral Pill — FDA Approved
The first and only FDA-approved GLP-1 pill specifically for weight loss. Launched commercially January 2026. Additionally, the Wegovy 7.2mg higher-dose injectable is now available as of 2026.
2025–2026
GLP-1 Usage Doubles
Gallup: ~6% to 12.4% of U.S. adults. Obesity rate: 40% (2022) to 37% (2025).
Regulatory Watch
Compounding market transition (Feb 6, 2026): The FDA announced a major enforcement action specifically targeting "mass-marketed" compounded GLP-1 alternatives.
503A personalized compounding — narrow exception remains: Compounding pharmacies operating under Section 503A technically retain the ability to prepare GLP-1 medications for specific, documented patient needs. This requires individual prescriptions with a bona fide patient-specific medical justification, not mass-market distribution.
Anti-kickback laws: Illegal in ~30 states to pay for physician referrals. Revenue-sharing arrangements require legal review regardless of how they are structured.
CMS BALANCE Model — lifestyle provider opportunity (Jan 2026): CMS formally announced the BALANCE Model (Better Approaches to Lifestyle and Nutrition for Comprehensive hEalth). Coverage begins: Medicaid May 2026, Medicare Part D bridge July 2026 ($50/mo copay), full Medicare Part D January 2027. Fitness brands that achieve "authorized lifestyle provider" designation gain a government-funded referral pipeline. Operators should begin the qualification process now.
Liability: Adverse GLP-1 reactions through fitness brand partnerships may expose brands to legal action. This risk is heightened if a telehealth partner was providing compounded medications. Carry appropriate insurance and audit all partner agreements.
The Trainer Readiness Gap
Every program in this report emphasizes the same thing: GLP-1 users need qualified fitness professionals. Yet the industry lacks standardized education.
What Trainers Need to Know
Muscle preservation: Up to 50% of weight lost can be lean mass without resistance training. Progressive overload is essential.
Energy management: GLP-1s suppress appetite. Clients may be under-fueled. Adjust intensity, volume, timing.
Nutrition guidance: High-protein intake critical. Know when to guide vs. refer to a registered dietitian.
Side effect awareness: Nausea, fatigue, GI distress, dehydration. Know when to modify or refer.
Behavioral coaching: Many GLP-1 users are first-time gym-goers. Welcoming experience drives retention.
Scope of Practice: Understanding the boundary between fitness coaching and medical advice to ensure member safety and brand liability protection.
Closing the Trainer Readiness Gap
To address the "Trainer Readiness Gap," Inspire360 is launching a premier specialty certification developed in partnership with leading clinical experts to provide clinician-backed education for fitness professionals. This comprehensive solution, alongside targeted CEC courses, equips trainers with the critical scope of practice physiological protocols needed to safely manage the unique needs of members on GLP-1 medications. By bridging this expertise gap, you ensure your staff can confidently deliver the resistance training and metabolic guidance essential for preventing muscle loss and driving long-term member results.
If there is a program we have missed, please let us know by emailing Kelli Pease at kelli@inspire360.com.
Methodology & Sources
Compiled from earnings calls, press releases, SEC filings, industry media, and verified reporting. This report does not constitute investment, legal, or medical advice.
